drugset / Trial / NCT04649710
A Study to Evaluate the Drug Levels and Safety of Pegbelfermin in Healthy Overweight and Obese Chinese and Korean Participants
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, and drug level of Pegbelfermin in healthy overweight and obese Chinese and Korean participants.
Timeline
- Start
- 2021-06-21
- Primary completion
- 2021-09-21
- Completion
- 2021-09-22
Outcome
Outcome not reported
Stopped (Business): “Business objectives have changed”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pegbelfermin | Protein / enzyme biologic | — | — |
Indications
No indication recorded.